Press Releases

Harren Jhoti receives BIA Lifetime Achievement Award at Annual Gala Dinner

Harren Jhoti, co-founder of Astex and President and CEO of Astex Pharmaceuticals, was awarded the BioIndustry Association (BIA) Lifetime Achievement Award at the BIA’s annual Gala Dinner last night.

New report reveals UK has the strongest R&D pipeline in Europe and the UK sector is maturing

‘Pipeline Progressing: the UK’s global bioscience cluster in 2017’ launched by the BioIndustry Association and Informa Pharma Intelligence

The State of the Drug Discovery Nation unveiled as new report provides vital insights for the development of new medicines

The Medicines Discovery Catapult and BioIndustry Association call on the R&D community to address five themes to help boost productivity

BIA welcomes the release of the AMR Industry Alliance’s first progress report

The BIA today welcomes the release of the AMR Industry Alliance’s first progress report assessing the action being taken to tackle antimicrobial resistance.

 

Member News

Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy

New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, supported by Science Foundation Ireland.

Horizon Discovery enters into license agreement with US immuno-oncology company

• Horizon out-licenses proprietary cell line and Helitron transposon gene editing technologies, demonstrating Horizon’s ability to generate revenues from internally derived IP • Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards, and cell therapy

Positive results achieved in ReViral's Phase IIa RSV challenge study

ReViral, a UK-based biotech company focused on developing novel compounds targeting respiratory syncytial virus (RSV), today announced successful results from its Phase IIa placebo-controlled challenge trial in healthy adult subjects infected intranasally with respiratory syncytial virus (RSV).

Congenica Signs Strategic Digital Health Contracts During Official UK-China Trade Mission

Congenica, the global provider of clinical genomics interpretation software, signed a series of significant memorandums of understanding (MOUs) with leading Chinese companies and healthcare providers at a UK-Chinese Future of Medicine trade event in Beijing, China. The meeting was held in conjunction with the State visit of Prime Minister May.

 

BIA blog

Guest blog: The Impact of the Patent Box on the UK life sciences sector

The BIA has published a new guide to the Patent Box, developed by members of the Finance and Tax Advisory Committee and to be officially launched at the BIA Committee Summit on 22 February. Here, FTI Consulting’s Richard Turner takes a look at the impact the Patent Box has had on the UK life sciences sector.

CEO Update: Monday 19 February

This week we are gearing up for our 2018 Committee Summit taking place on Thursday, kindly hosted by Simmons and Simmons. The event will see around 180 expert BIA members gather for all eight of the BIA’s advisory committees coming together. In addition, this year we are running a plenary session on the implications of the Nagoya protocol for our sector.

Looking Back: Highlights from our 2017 Partnership with Alzheimer’s Research UK

The BIA’s Charity of the Year for 2017 was Alzheimer’s Research UK, and we are proud to have supported them throughout the year. In this blog, we take a quick look back at some of the highlights of our partnership.

CEO Update: Monday 12 February

Thank you to all our members who joined our Brexit lead event last week. It was great to be able to share perspectives on what is a fast moving key issue. I was pleased that members confirmed that we should stay our course on the Brexit priorities agreed last year, which we will keep stressing to the UK government, and with our European partner associations to the EU-27.

 

Our publications

Please find a selection of featured BIA publications below. To see our full publications library, click here

Influencing and shaping our sector, BIA update - October 2017 - January 2018

An overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders from October 2017 to January 2018.

Pipeline Progressing: The UK's Global Bioscience Cluster in 2017

A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence reveals that the UK has the strongest clinical and preclinical pipeline in Europe.

Growing the next generation of UK management talent

BIA directory of industry training opportunities to help build the next generation of management talent.

A vision for the UK life sciences sector in 2025

This vision, developed in consultation with the BIA Board and sector experts, sets out an ambitious goal for the UK to become a top global cluster in life sciences by 2025.